C. Schnack et al., PULMONARY DYSFUNCTION IN TYPE-1 DIABETES IN RELATION TO METABOLIC LONG-TERM CONTROL AND TO INCIPIENT DIABETIC NEPHROPATHY, Nephron, 74(2), 1996, pp. 395-400
The available data on pulmonary function in type 1 diabetes are still
conflicting. Recently, restrictive alterations of pulmonary function w
ere demonstrated in type 1 diabetic patients with end-stage renal fail
ure (diabetic nephropathy), whereas patients with kidney failure from
other causes had normal pulmonary function test results. In this study
, the prevalence and nature of pulmonary dysfunction in type 1 diabete
s and the relationship of pulmonary function tests to incipient diabet
ic nephropathy and metabolic long-term control were analyzed. Pulmonar
y function tests were performed in longstanding type 1 diabetic patien
ts (n = 39) with normal serum creatinine levels (< 1.3 mg/dl) and the
results compared with those of healthy controls (n = 44). The patients
were divided into those with a normal urinary albumin excretion rate
(AER; n = 21, <30 mg/day) and those with microalbuminuria (n = 18, AER
30-300 mg/day). We found a significant reduction of the following pul
monary function tests (performed by standardized spirometry and whole-
body plethysmography) as compared with controls (C) in diabetic patien
ts with microalbuminuria (M) and in diabetic patients with normoalbumi
nuria (N): total lung capacity (TLC; % predicted: M 89.6, p < 0.004; N
98.5, p = NS; C 101.1), vital capacity (VC; % predicted: M 83.7, p <
0.001; N 90.2, p < 0.03; C 97.3), forced expiratory volume in 1 s (FEV
(1); % predicted: M 81.2, p < 0.002; N 88.8, p < 0.02; C 93.8), and di
ffusing capacity of the lung for CO (DLCO; % predicted: M 83.4, p < 0.
04; N 92.4, p = NS; C 95.6). We also found a slight increase of the ai
rway resistance (kPa/l/s: M 0.22, p < 0.03; N 0.2, p = NS; C 0.18). Th
e differences in TLC (% predicted) between diabetic patients with norm
o- and microalbuminuria were significant (p < 0.04). Further a close r
elation of pulmonary function tests to metabolic long-term control (me
an values of repeated HbA(1c) measurements) was observed: TLC (% predi
cted: M r -0.61, p < 0.007, N p = NS), VC (% predicted: M r = -0.57, p
< 0.01; N r = -0.59, p < 0.005), and FEV(1) (% predicted: M r = -0.50
, p < 0.03; N r = -0.62, p < 0.003). In conclusion: pulmonary dysfunct
ion in long-standing type I diabetic patients is more pronounced in pa
tients with increased AER. Typical features of restrictive pulmonary d
efects, namely a reduction of TLC (% predicted) plus DLCO (% predicted
) were observed predominantly in patients with incipient diabetic neph
ropathy. The clear correlation of pulmonary function tests with HbA(1c
) measurements stresses the importance of optimal metabolic long-term
control in type 1 diabetes.